Loading…
Reported covered position: Dep. Staff Director and Chief Counsel, Senate Appropriations Cmt; Chief Counsel Civil Law and Oversight, Sen. Counsel, Sen. Judiciary Cmt; Leg Asst. and Projects Dir., Leg. Corresp., Senator Leahy
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
H.R. 2405 (White Oak Resilience Act) and S. 476 (White Oak Resilience Act) relating to the availability of white oak; forestry-related provisions in agriculture-related legislation; H.R. 471 (Fix Our Forests Act); issues related to intoxicating hemp
H.R. 2405 (White Oak Resilience Act) and S. 476 (White Oak Resilience Act) relating to the availability of white oak; forestry-related provisions in agriculture-related legislation; H.R. 471 (Fix Our Forests Act); issues related to intoxicating hemp
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
2026 · third_quarter · Q3
Issues regarding AI, financial management services, and workforce modernization
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · RR
Source: Senate LDA
| NATIONAL CAPITOL CONTRACTING, LLC |
| 11 |
| 2024–2026 |
| AUSTAL USA | 10 | 2024–2026 |
| HEALTH SUPPLY US | 10 | 2023–2026 |
| PARATEK PHARMACEUTICALS | 10 | 2024–2026 |
| URSA MAJOR TECHNOLOGIES, INC. | 10 | 2024–2026 |
| AMERICAN EXPLORATION & PRODUCTION COUNCIL | 9 | 2024–2026 |
| DOORDASH | 9 | 2024–2026 |
| ORCHARD THERAPEUTICS NORTH AMERICA | 9 | 2024–2026 |
| ABBOTT LABORATORIES | 8 | 2025–2026 |
| AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. | 8 | 2024–2026 |
| BLUE ORIGIN, LLC | 8 | 2025–2026 |
| COUNCIL ON FOUNDATIONS INC. | 8 | 2025–2026 |
| KATAHDIN IMPACT INC. | 8 | 2025–2026 |
| NATIONAL FOOTBALL LEAGUE | 8 | 2024–2026 |
| PARSONS CORPORATION | 8 | 2024–2026 |
| SANDOZ INC. | 8 | 2024–2026 |
| SHIELD AI | 8 | 2025–2026 |
| COALTION FOR ADULT BEVERAGE ALTERNATIVES | 7 | 2025–2026 |
| GOOGLE CLIENT SERVICES LLC | 7 | 2025–2026 |
| INTEGRAL AD SCIENCE | 7 | 2025 |
| THE BOEING COMPANY | 7 | 2025–2026 |
| BLACKWATCH INTERNATIONAL | 6 | 2024–2025 |
| NATIONAL ALLIANCE FOR BETTER NUTRITION | 6 | 2025–2026 |
| COHESITY, INC. | 5 | 2025–2026 |
| ESSITY NORTH AMERICA INC. | 5 | 2025–2026 |
| FOUNDATION STACK AI, INC. | 5 | 2024–2025 |
| GEA MECHANICAL EQUIPMENT US, INC. | 5 | 2025–2026 |
| GENERAL ATOMICS AERONAUTICAL SYSTEMS, INC. | 5 | 2025–2026 |
| KELLER POSTMAN | 5 | 2023–2024 |
| S&P GLOBAL | 5 | 2025–2026 |
| LEGO SYSTEMS, INC. | 4 | 2024–2025 |
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 4 | 2025–2026 |
| MORRISON COHEN, LLP OBO REXMARK HOLDINGS, LLC | 4 | 2024–2025 |
| OSHKOSH CORPORATION | 4 | 2025–2026 |
| ALKERMES, INC. | 3 | 2026 |
| PET FOOD INSTITUTE | 3 | 2026 |
| SAZERAC COMPANY, INC. | 3 | 2026 |
| WAYMO LLC | 3 | 2026 |
| NELNET | 2 | 2026 |
| STANDARD INDUSTRIES LTD. | 2 | 2023 |
| WALMART INC | 2 | 2026 |
| WORKDAY, INC. | 2 | 2026 |
| SKYDIO, INC. | 1 | 2026 |
H.R. 2405 (White Oak Resilience Act) and S. 476 (White Oak Resilience Act) relating to the availability of white oak; forestry-related provisions in agriculture-related legislation; H.R. 471 (Fix Our Forests Act); issues related to intoxicating hemp
Reserved for the Speaker.
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Reserved for the Speaker.
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
H.R. 2405 (White Oak Resilience Act) and S. 476 (White Oak Resilience Act) relating to the availability of white oak; forestry-related provisions in agriculture-related legislation; H.R. 471 (Fix Our Forests Act); issues related to intoxicating hemp
H.R. 2405 (White Oak Resilience Act) and S. 476 (White Oak Resilience Act) relating to the availability of white oak; forestry-related provisions in agriculture-related legislation; H.R. 471 (Fix Our Forests Act); issues related to intoxicating hemp
H.R. 2405 (White Oak Resilience Act) and S. 476 (White Oak Resilience Act) relating to the availability of white oak; forestry-related provisions in agriculture-related legislation; H.R. 471 (Fix Our Forests Act); issues related to intoxicating hemp
H.R. 2405 (White Oak Resilience Act) and S. 476 (White Oak Resilience Act) relating to the availability of white oak; forestry-related provisions in agriculture-related legislation; H.R. 471 (Fix Our Forests Act); issues related to intoxicating hemp
H.R. 2405 (White Oak Resilience Act) and S. 476 (White Oak Resilience Act) relating to the availability of white oak; forestry-related provisions in agriculture-related legislation; H.R. 471 (Fix Our Forests Act); issues related to intoxicating hemp
H.R. 2405 (White Oak Resilience Act) and S. 476 (White Oak Resilience Act) relating to the availability of white oak; forestry-related provisions in agriculture-related legislation; H.R. 471 (Fix Our Forests Act); issues related to intoxicating hemp
Farm, Food, and National Security Act of 2024
Client: COALTION FOR ADULT BEVERAGE ALTERNATIVES · Firm: S-3 GROUP
General hemp issues; H.R. 8467 - Family, Food, and National Security Act of 2024
Farm, Food, and National Security Act of 2024
Client: COALTION FOR ADULT BEVERAGE ALTERNATIVES · Firm: S-3 GROUP
General hemp issues; H.R. 8467 - Family, Food, and National Security Act of 2024
Farm, Food, and National Security Act of 2024
Client: COALTION FOR ADULT BEVERAGE ALTERNATIVES · Firm: S-3 GROUP
General hemp issues; H.R. 8467 - Family, Food, and National Security Act of 2024
Prescription Drug Price Relief Act of 2019
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Prescription Drug Price Relief Act of 2019
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Reserved for the Speaker.
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Reserved for the Speaker.
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Reserved for the Speaker.
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Reserved for the Speaker.
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Farm, Food, and National Security Act of 2024
Client: COALTION FOR ADULT BEVERAGE ALTERNATIVES · Firm: S-3 GROUP
General hemp issues; H.R. 8467 - Family, Food, and National Security Act of 2024
Farm, Food, and National Security Act of 2024
Client: COALTION FOR ADULT BEVERAGE ALTERNATIVES · Firm: S-3 GROUP
General hemp issues; H.R. 8467 - Family, Food, and National Security Act of 2024
Farm, Food, and National Security Act of 2024
Client: COALTION FOR ADULT BEVERAGE ALTERNATIVES · Firm: S-3 GROUP
General hemp issues; H.R. 8467 - Family, Food, and National Security Act of 2024
Farm, Food, and National Security Act of 2024
Client: COALTION FOR ADULT BEVERAGE ALTERNATIVES · Firm: S-3 GROUP
General hemp issues; H.R. 8467 - Family, Food, and National Security Act of 2024
Prescription Drug Price Relief Act of 2019
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Prescription Drug Price Relief Act of 2019
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Prescription Drug Price Relief Act of 2019
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Prescription Drug Price Relief Act of 2019
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Reserved for the Speaker.
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019; issues related to Safe Step Act
Prescription Drug Price Relief Act of 2019
Client: AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Firm: S-3 GROUP
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019; issues related to Safe Step Act
Issues regarding AI, financial management services, and workforce modernization
ESSITY NORTH AMERICA INC. via S-3 GROUP
2026 · third_quarter · Q3
Advocacy related to product regulatory issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Q3
Issues related to privacy, data security, and funding
Issues related to privacy and data security
Issues related to privacy, data security, and funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to autonomous vehicles
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OSHKOSH CORPORATION via S-3 GROUP
2026 · third_quarter · Q3
US manufacturing and international competitiveness
US manufacturing and international competitiveness
US manufacturing and international competitiveness
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to autonomous platforms for border and national security
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Q3
Issues related to privacy
Issues related to trade
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KATAHDIN IMPACT INC. via S-3 GROUP
2026 · third_quarter · Q3
Issues related to the park service and efficient use of federal lands
Advocating for advanced super intelligence academic computing, regional consortiums, and CREATES Act
Issues related to the advancement of Artificial Intelligence
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COUNCIL ON FOUNDATIONS INC. via S-3 GROUP
2026 · third_quarter · Q3
Strategies and policy advice on tax policy matters with respect to the philanthropic sector
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via S-3 GROUP
2026 · third_quarter · Q3
Issues related to infant formula
Proposals to reform domestic and international tax structures
Equitable Access to Community Pharmacist Services Act
Issues related to student loans
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MASSACHUSETTS INSTITUTE OF TECHNOLOGY via S-3 GROUP
2026 · third_quarter · Q3
Issues related to higher education
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLUE ORIGIN, LLC via S-3 GROUP
2026 · third_quarter · Q3
Issues related to launch logistics in FY 26 defense appropriations and authorizations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARATEK PHARMACEUTICALS via S-3 GROUP
2026 · third_quarter · Q3
Funding for countermeasures in BARDA and DoD
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
URSA MAJOR TECHNOLOGIES, INC. via S-3 GROUP
2026 · third_quarter · 3T
Issues related to defense space propulsion and export controls
Issues related to defense space propulsion and export controls
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORCHARD THERAPEUTICS NORTH AMERICA via S-3 GROUP
2026 · third_quarter · Q3
Issues related to funding for newborn screenings for metachromatic leukodystrophy
Issues related to funding for newborn screenings for metachromatic leukodystrophy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
URSA MAJOR TECHNOLOGIES, INC. via S-3 GROUP
2026 · third_quarter · Q3
Issues related to defense space propulsion and export controls
Issues related to defense space propulsion and export controls
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN EXPLORATION & PRODUCTION COUNCIL via S-3 GROUP
2026 · third_quarter · Q3
Monitor issues and legislation to support the resonsible production of American oil and gas
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALTION FOR ADULT BEVERAGE ALTERNATIVES via S-3 GROUP
2026 · third_quarter · Q3
FY2026 Appropriations
General hemp issues; H.R. 8467 - Family, Food, and National Security Act of 2024
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTH SUPPLY US via S-3 GROUP
2026 · third_quarter · Q3
Domestic industrial base and public health supply chain issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL CAPITOL CONTRACTING LLC via S-3 GROUP
2026 · third_quarter · Q3
Defense, Navy, RDTE, Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to tax filing
Issues related to tax filing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANDOZ INC. via S-3 GROUP
2026 · third_quarter · Q3
Issues and legislative proposals on biosimilars and generics medicines, including but not limited to generics and biosimilar sustainability, pharmaceutical supply chain security, drug shortages, interchangeability, patent litigation, and PBM reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AIR LINE PILOTS ASSOCIATION via S-3 GROUP
2026 · third_quarter · Q3
Issues specific to aviation and pilots
General aviation issues
Aviation safety; single pilot operations
Defense Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues pertaining to policy matters impacting labor, independent workers, gig economy, consumer issues and food, restaurant, small businesses
Issues pertaining to policy matters impacting labor, independent workers, gig economy, consumer issues and food, restaurant, small businesses
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE OF COMMUNITY HEALTH PLANS via S-3 GROUP
2026 · third_quarter · Q3
Issues related to healthcare; Medicare Advantage and Medicaid
Issues related to healthcare; Medicare Advantage and Medicaid
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARSONS CORPORATION via S-3 GROUP
2026 · third_quarter · Q3
FY2027 Funding for Defense programs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENERAL ATOMICS AERONAUTICAL SYSTEMS, INC. via S-3 GROUP
2026 · third_quarter · Q3
FY2026 Defense Appropriations; FY2026 Homeland Security Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PET FOOD INSTITUTE via S-3 GROUP
2026 · third_quarter · Q3
Provide more efficient oversight of pet food and pet food products
Provide more efficient oversight of pet food and pet food products
Provide more efficient oversight of pet food and pet food products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE TO MODERNIZE PRESCRIBING INFORMATION via S-3 GROUP
2026 · third_quarter · Q3
Advocating for electronic labeling for prescribers only
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AUSTAL USA via S-3 GROUP
2026 · third_quarter · Q3
Issues related to shipbuilding in Defense and Homeland Security Appropriations bills
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAZERAC COMPANY, INC. via S-3 GROUP
2026 · third_quarter · Q3
Proposed tariffs and impact on exports and imports of distilled spirits.
Food and beverage policy issues, including U.S. dietary guidelines; support appropriations or U.S. Alcohol and Tobacco Tax and Trade Bureau; issues pertaining to the alcohol industry.
Issues related to duty drawback and alcohol taxes.
AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. via S-3 GROUP
2026 · third_quarter · Q3
Issues related to Rx drug pricing
Issues related to health care research
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LVMH MOET HENNESSY LOUIS VUITTON INC. via S-3 GROUP
2026 · third_quarter · Q3
Federal policy relating to general tax policy, trade agreements, consumer protection, and general regulatory matters impacting the fashion, wines and spirits, perfume and cosmetic, watch and jewelry, and related luxury products industry
Federal policy relating to general tax policy, trade agreements, consumer protection, and general regulatory matters impacting the fashion, wines and spirits, perfume and cosmetic, watch and jewelry, and related luxury products industry
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, White House Office
GOOGLE CLIENT SERVICES, LLC via S-3 GROUP
2026 · third_quarter · Q3
Issues related to human trafficking efforts and criminal justice reform
Issues related to intellectual property enforcement
Issues related to competition in online services
2026 · third_quarter · Q3
Issues related to legislation and policies that support treatment for alcohol and opioid dependency at SAMSHA, VA and DOJ
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S&P GLOBAL via S-3 GROUP
2026 · third_quarter · Q3
Issues related to credit rating agencies and commodity/ financial derivatives and benchmarks; privacy issues
Issues related to the pricing of aluminum
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE BOEING COMPANY via S-3 GROUP
2026 · third_quarter · Q3
Issues addressed in FY27 Appropriations / NDAA
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · fourth_quarter · RR
Issues related to U.S. manufacturing and use of unmanned aircraft systems, including appropriations and legislation affecting public safety, homeland security, and national security.
Issues related to U.S. manufacturing and use of unmanned aircraft systems, including appropriations and legislation affecting public safety, homeland security, and national security.
Issues related to U.S. manufacturing and use of unmanned aircraft systems, including appropriations and legislation affecting public safety, homeland security, and national security.
HEALTH SUPPLY US via S-3 GROUP
2026 · second_quarter · Q2
Domestic industrial base and public health supply chain issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTH SUPPLY US via S-3 GROUP
2026 · second_quarter · RA
Domestic industrial base and public health supply chain issues
ESSITY NORTH AMERICA INC. via S-3 GROUP
2026 · second_quarter · Q2
Advocacy related to product regulatory issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Q2
Issues related to privacy, data security, and funding
Issues related to privacy, data security, and funding
Issues related to privacy and data security
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to autonomous vehicles
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OSHKOSH CORPORATION via S-3 GROUP
2026 · second_quarter · Q2
US manufacturing and international competitiveness
US manufacturing and international competitiveness
US manufacturing and international competitiveness
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to autonomous platforms for border and national security
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Q2
Issues related to trade
Issues related to privacy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KATAHDIN IMPACT INC. via S-3 GROUP
2026 · second_quarter · Q2
Issues related to the advancement of Artificial Intelligence
Issues related to the park service and efficient use of federal lands
Development and expansion of National AI a multi-state consortium focused on advanced compute
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COUNCIL ON FOUNDATIONS INC. via S-3 GROUP
2026 · second_quarter · Q2
Strategies and policy advice on tax policy matters with respect to the philanthropic sector
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via S-3 GROUP
2026 · second_quarter · Q2
Proposals to reform domestic and international tax structures
Equitable Access to Community Pharmacist Services Act
Equitable Access to Community Pharmacist Services Act
Issues related to student loans
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MASSACHUSETTS INSTITUTE OF TECHNOLOGY via S-3 GROUP
2026 · second_quarter · Q2
Issues related to higher education
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLUE ORIGIN, LLC via S-3 GROUP
2026 · second_quarter · Q2
Issues related to launch logistics in FY 26 defense appropriations and authorizations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARATEK PHARMACEUTICALS via S-3 GROUP
2026 · second_quarter · Q2
Funding for countermeasures in BARDA and DoD
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORCHARD THERAPEUTICS NORTH AMERICA via S-3 GROUP
2026 · second_quarter · Q2
Issues related to funding for newborn screenings for metachromatic leukodystrophy
Issues related to funding for newborn screenings for metachromatic leukodystrophy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
URSA MAJOR TECHNOLOGIES, INC. via S-3 GROUP
2026 · second_quarter · Q2
Issues related to defense space propulsion and export controls
Issues related to defense space propulsion and export controls
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN EXPLORATION & PRODUCTION COUNCIL via S-3 GROUP
2026 · second_quarter · Q2
Monitor issues and legislation to support the resonsible production of American oil and gas
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALTION FOR ADULT BEVERAGE ALTERNATIVES via S-3 GROUP
2026 · second_quarter · Q2
FY2026 Appropriations
General hemp issues; H.R. 8467 - Family, Food, and National Security Act of 2024
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL CAPITOL CONTRACTING LLC via S-3 GROUP
2026 · second_quarter · Q2
Defense, Navy, RDTE, Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to tax filing
Issues related to tax filing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANDOZ INC. via S-3 GROUP
2026 · second_quarter · Q2
Issues and legislative proposals on biosimilars and generics medicines, including but not limited to generics and biosimilar sustainability, pharmaceutical supply chain security, drug shortages, interchangeability, patent litigation, and PBM reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AIR LINE PILOTS ASSOCIATION via S-3 GROUP
2026 · second_quarter · Q2
General aviation issues
General aviation issues
Issues specific to aviation and pilots
Defense Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues pertaining to policy matters impacting labor, independent workers, gig economy, consumer issues and food, restaurant, small businesses
Issues pertaining to policy matters impacting labor, independent workers, gig economy, consumer issues and food, restaurant, small businesses
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE OF COMMUNITY HEALTH PLANS via S-3 GROUP
2026 · second_quarter · Q2
Issues related to healthcare; Medicare Advantage and Medicaid
Issues related to healthcare; Medicare Advantage and Medicaid
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARSONS CORPORATION via S-3 GROUP
2026 · second_quarter · Q2
FY2027 Funding for Defense programs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENERAL ATOMICS AERONAUTICAL SYSTEMS, INC. via S-3 GROUP
2026 · second_quarter · Q2
FY2026 Defense Appropriations; FY2026 Homeland Security Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PET FOOD INSTITUTE via S-3 GROUP
2026 · second_quarter · Q2
Provide more efficient oversight of pet food and pet food products
Provide more efficient oversight of pet food and pet food products
Provide more efficient oversight of pet food and pet food products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE TO MODERNIZE PRESCRIBING INFORMATION via S-3 GROUP
2026 · second_quarter · Q2
Advocating for electronic labeling for prescribers only
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AUSTAL USA via S-3 GROUP
2026 · second_quarter · Q2
Issues related to shipbuilding in Defense and Homeland Security Appropriations bills
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAZERAC COMPANY, INC. via S-3 GROUP
2026 · second_quarter · Q2
Issues relating to counterfeit and illegal sales of alcoholic beverages
Issues related to duty drawback and alcohol taxes.
Food and beverage policy issues, including U.S. dietary guidelines; support appropriations or U.S. Alcohol and Tobacco Tax and Trade Bureau; issues pertaining to the alcohol industry.
AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. via S-3 GROUP
2026 · second_quarter · Q2
Issues related to health care research
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LVMH MOET HENNESSY LOUIS VUITTON INC. via S-3 GROUP
2026 · second_quarter · Q2
Federal policy relating to general tax policy, trade agreements, consumer protection, and general regulatory matters impacting the fashion, wines and spirits, perfume and cosmetic, watch and jewelry, and related luxury products industry
Federal policy relating to general tax policy, trade agreements, consumer protection, and general regulatory matters impacting the fashion, wines and spirits, perfume and cosmetic, watch and jewelry, and related luxury products industry
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, White House Office
GOOGLE CLIENT SERVICES, LLC via S-3 GROUP
2026 · second_quarter · Q2
Issues related to human trafficking efforts and criminal justice reform
Issues related to intellectual property enforcement
Issues related to funding in Appropriations bills and internet governance
2026 · second_quarter · Q2
Issues related to legislation and policies that support treatment for alcohol and opioid dependency at SAMSHA, VA and DOJ
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S&P GLOBAL via S-3 GROUP
2026 · second_quarter · Q2
Issues related to the pricing of aluminum
Issues related to credit rating agencies and commodity/ financial derivatives and benchmarks; privacy issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE BOEING COMPANY via S-3 GROUP
2026 · second_quarter · Q2
Issues addressed in FY27 Appropriations / NDAA
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ESSITY NORTH AMERICA INC. via S-3 GROUP
2026 · first_quarter · Q1
Advocacy related to product regulatory issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Q1
Issues related to privacy and data security
Issues related to privacy, data security, and funding
Issues related to privacy, data security, and funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to autonomous vehicles
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OSHKOSH CORPORATION via S-3 GROUP
2026 · first_quarter · Q1
US manufacturing and international competitiveness
US manufacturing and international competitiveness
US manufacturing and international competitiveness
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to autonomous platforms for border and national security
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KATAHDIN IMPACT INC. via S-3 GROUP
2026 · first_quarter · Q1
Issues related to the park service and efficient use of federal lands
Development and expansion of National AI a multi-state consortium focused on advanced compute
Issues related to the advancement of Artificial Intelligence
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COUNCIL ON FOUNDATIONS INC. via S-3 GROUP
2026 · first_quarter · Q1
Strategies and policy advice on tax policy matters with respect to the philanthropic sector
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via S-3 GROUP
2026 · first_quarter · Q1
Equitable Access to Community Pharmacist Services Act
Equitable Access to Community Pharmacist Services Act
Proposals to reform domestic and international tax structures
MASSACHUSETTS INSTITUTE OF TECHNOLOGY via S-3 GROUP
2026 · first_quarter · Q1
Issues related to higher education
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLUE ORIGIN, LLC via S-3 GROUP
2026 · first_quarter · Q1
Issues related to launch logistics in FY 26 defense appropriations and authorizations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARATEK PHARMACEUTICALS via S-3 GROUP
2026 · first_quarter · Q1
Funding for countermeasures in BARDA and DoD
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARATEK PHARMACEUTICALS via S-3 GROUP
2026 · first_quarter · Q1
Funding for countermeasures in BARDA and DoD
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORCHARD THERAPEUTICS NORTH AMERICA via S-3 GROUP
2026 · first_quarter · Q1
Issues related to funding for newborn screenings for metachromatic leukodystrophy
Issues related to funding for newborn screenings for metachromatic leukodystrophy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
URSA MAJOR TECHNOLOGIES, INC. via S-3 GROUP
2026 · first_quarter · Q1
Issues related to defense space propulsion and export controls
Issues related to defense space propulsion and export controls
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN EXPLORATION & PRODUCTION COUNCIL via S-3 GROUP
2026 · first_quarter · Q1
Monitor issues and legislation to support the resonsible production of American oil and gas
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALTION FOR ADULT BEVERAGE ALTERNATIVES via S-3 GROUP
2026 · first_quarter · Q1
General hemp issues; H.R. 8467 - Family, Food, and National Security Act of 2024
FY2026 Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL CAPITOL CONTRACTING LLC via S-3 GROUP
2026 · first_quarter · Q1
Defense, Navy, RDTE, Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to tax filing
Issues related to tax filing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANDOZ INC. via S-3 GROUP
2026 · first_quarter · Q1
Issues and legislative proposals on biosimilars and generics medicines, including but not limited to generics and biosimilar sustainability, pharmaceutical supply chain security, drug shortages, interchangeability, patent litigation, and PBM reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AIR LINE PILOTS ASSOCIATION via S-3 GROUP
2026 · first_quarter · Q1
Issues involving mandatory retirement age for pilots
General aviation issues
Issues specific to aviation and pilots
Defense Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Equitable Access to Community Pharmacist Services Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
General aviation issues
Issues relating to No Tax On Overtime provision
Issues involving mandatory retirement age for pilots
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 2405 (White Oak Resilience Act) and S. 476 (White Oak Resilience Act) relating to the availability of white oak; forestry-related provisions in agriculture-related legislation; H.R. 471 (Fix Our Forests Act); issues related to intoxicating hemp
Issues relating to counterfeit and illegal sales of alcoholic beverages
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to funding in Appropriations bills and internet governance
Issues related to privacy and data security
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to U.S. manufacturing and use of unmanned aircraft systems, including appropriations and legislation affecting public safety, homeland security, and national security.
Issues related to infant formula
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues relating to No Tax On Overtime provision
Aviation safety; single pilot operations
Issues involving mandatory retirement age for pilots
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Proposed tariffs and impact on exports and imports of distilled spirits.
H.R. 2405 (White Oak Resilience Act) and S. 476 (White Oak Resilience Act) relating to the availability of white oak; forestry-related provisions in agriculture-related legislation; H.R. 471 (Fix Our Forests Act); issues related to intoxicating hemp
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to competition in online services
Issues related to privacy and data security
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to infant formula
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues relating to No Tax On Overtime provision
General aviation issues
Aviation safety; single pilot operations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE